Fundraising FoxNeurolentech
1 known investors
Find your way into Neurolentech
Sign up to see every warm intro you have to Neurolentech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neurolentech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neurolentech develops therapeutics for neurodevelopmental disorders such as epilepsy, intellectual disability, and severe autism, using patient-derived neuronal cell models to identify druggable targets and accelerate drug discovery. It works with clinicians and patient foundations, including the Tess Foundation, to develop treatments for indications like SLC13A5 epilepsy.
Investors · 1
Frequently asked questions
- What does Neurolentech do?
- Neurolentech develops therapeutics for neurodevelopmental disorders such as epilepsy, intellectual disability, and severe autism, using patient-derived neuronal cell models to identify druggable targets and accelerate drug discovery. It works with clinicians and patient foundations, including the Tess Foundation, to develop treatments for indications like SLC13A5 epilepsy.
- Who are Neurolentech's investors?
- Neurolentech's investors include xista science ventures.